Absolute CD3 Count: What CD3 Measures and How to Read Your Result

At a Glance

CD3 is not a disease, a condition or a risk score. It is a protein complex that sits on the surface of mature T-lymphocytes, and laboratories use it as the way to recognize a T cell. The National Library of Medicine defines the CD3 complex as a group of at least five membrane-bound polypeptides on mature T-lymphocytes, linked to the T-cell receptor, which passes the activating signal into the cell when the receptor meets its antigen.

So the absolute CD3 count is a headcount: how many T-lymphocytes are in a microliter of your blood. LOINC files it under the class CELLMARK — a cell marker — rather than under a chemistry class, which is the standard vocabulary's way of saying the same thing.

Two things are worth settling before the number means anything:

• Check the scale. LOINC records three example units for this analyte: #/mm3, /uL and 10^9/L. The first two are the same size — one cubic millimetre is one microliter. The third is not: multiply a figure in 10^9/L by 1,000 to get /uL, so 1.5 x10^9/L is 1500 /uL. This library stores CD3 both ways.
• Check whose interval you are being compared with. The range on this record is one laboratory's, and published intervals for CD3 differ between populations — see below.

How to read your result

The range stored on this record is 622 - 2402 /uL and the field is labeled Optimal Result. Treat it as one laboratory's reference interval rather than a target. A reference interval describes where most of a reference population fell; it is not a goal to aim at.

This particular interval has a traceable origin, which is worth knowing. This record sits in the T + B-Lymphocyte Differential category, and Labcorp publishes for its test 096917 an adult CD3+ interval of 622–2402 cells/mm³ (58–86%) — the same figures, from the laboratory whose panel this is.

Published intervals do differ, though. A 2021 study in Annals of Translational Medicine established reference intervals in 496 healthy adults and reported CD3+ of 834.47–2,216.8 cells/µL (52.11–81.55%).

The two disagree most at the bottom. Someone at 700 /uL is inside the range stored here and below the study's. That is not an error to resolve — intervals differ with the population they were drawn from and the method used, and the study's authors attribute differences between countries to ethnicity, age and sex distribution, and method, while saying a race-based explanation cannot be confirmed without further international work. It is a reason to read the range printed on your own report rather than any range you find elsewhere, this one included.

This interval is an adult interval. Children need age-specific intervals, which vary by age, and reading a child's result against an adult range can misclassify it. If the result is a child's, the interval printed on that report is the one that applies.

What this test is actually used for

Labcorp names two uses for the panel this value comes from: enumerating lymphocyte subsets to classify and diagnose primary immunodeficiency diseases, and evaluating and monitoring patients with HIV — where, as below, it is the CD4 count rather than CD3 that carries the staging. The point of enumeration, in the laboratory's own framing, is to establish whether a subset is reduced or absent — a question about numbers, not about how well the cells work.

The CD3 count is the denominator of that panel rather than its conclusion. It tells you how many T cells there are in total. Which T cells, and whether they are doing their job, are different questions that the CD3 count does not answer.

If your result is flagged

Being flagged is a comparison with the range stored on this record, which is one interval among several. It is not a diagnosis, and on its own it does not identify a cause.

A low total T-cell count is the finding the panel is designed to detect, and it is the one to take to the clinician who ordered it, alongside the rest of the panel. A high total T-cell count is read against the rest of the blood count: the question is whether the lymphocyte count as a whole is raised, and what the clinical picture shows.

Neither direction is interpretable from this one number. The panel reports several values together for that reason.

If you remember only one thing

CD3 identifies T cells; it does not grade them. The count tells you how many T-lymphocytes you have, not how well they work, and not which subset is affected. Check the scale before anything else — /uL and #/mm3 are the same, and a 10^9/L figure is multiplied by 1,000 to give /uL — then check whose range you are being compared with, then read the number next to the rest of the panel and the person who ordered it.

Two people, same result

Two adults are both reported at 600 /uL — just below the range stored on this record, so both are flagged low.

The first was tested because of recurring infections, and the panel was ordered to look for a primary immunodeficiency. For her the flag is the measurement doing the job it was designed for: the laboratory names classifying primary immunodeficiency as an intended use, and a reduced subset count is what that evaluation looks for. What the figure does not do is name the condition. It establishes that the total is low; which subset is responsible, and why, comes from the rest of the panel and from the clinical picture.

The second had the panel drawn during an acute viral illness. His total is low today and the question is whether it is low in general — a single count taken during an infection describes that day. Nothing in the number distinguishes the two cases. The reason for the test does.

What this result cannot tell you

This is the limitation the rest of the page depends on.

It is not the HIV marker. The association is easy to make, because this panel is used in HIV care — but the number that does the work there is a different one. The CDC's Revised Surveillance Case Definition for HIV Infection — United States, 2014 stages HIV in adults and adolescents on the CD4+ count: stage 1 at ≥500 cells/µL or ≥26%, stage 2 at 200–499 or 14–25%, stage 3 at <200 or <14%. The document states the stage is based primarily on the CD4+ count, with the percentage used only when the count is missing. CD3 does not appear in that document at all. A normal CD3 is not reassurance about CD4, and a low CD3 does not stage anything.

It does not say which T cells. CD3 counts every T cell together — helper and cytotoxic cells among them, and others that carry both markers or neither. A normal total can sit on top of an abnormal split between them, which is why the panel reports the subsets and the ratio separately.

It does not measure how well the T cells work. Enumeration answers whether cells are present, not whether they function. A numerical immunodeficiency and a functional one are different findings.

It is a snapshot. The count describes the day the blood was drawn.

"CD3-positive" on a pathology report does not mean cancer. It means the cells in question are T cells — CD3 is how the laboratory identifies lineage. Peer-reviewed work makes the point concretely: a 2020 study in Diagnostics reviewed 140 peripheral blood samples sent for diagnostic flow cytometry and found an aberrant CD3-positive population in 18 of them, in acute Epstein-Barr virus infection, cytomegalovirus infection and after vaccination. Lymphoma was ruled out in all 18, and the population cleared on its own. Unusual-looking CD3-positive cells can be a reaction to a virus.

Common interpretation mistakes

Reading 10^9/L against a /uL range. Multiply by 1,000 first: 1.5 x10^9/L is 1500 /uL, comfortably inside the stored range.

Reading the stored range as a target. It is one laboratory's reference interval, and published intervals differ — most at the lower bound.

Reading a low CD3 as an HIV result. The staging system uses CD4 and does not mention CD3.

Reading "CD3-positive" as a cancer finding. It identifies the cells as T cells. Benign reactive populations occur.

Reading a child's result against this range. Adult interval; children need age-specific ones.

Reading the total without the subsets. A normal CD3 can contain an abnormal CD4:CD8 split.

Questions your doctor may ask

Why was this panel ordered, and what question was it meant to answer? Have you had an infection, or a vaccination, in the weeks before the draw? Do you take any medication that affects the immune system, including steroids or chemotherapy? What did the rest of the panel show — the percentage, the CD4 and CD8 counts, the ratio, the B cells? Is there an earlier result from the same laboratory to compare with? What units and what range did your report print? And what would change in your care depending on the answer?

Read together with

CD3 percentage is the same population expressed as a share of your lymphocytes rather than a concentration. A steady percentage can sit alongside a falling absolute count, if the lymphocyte total is falling too.

CD3+/CD4+ and CD3+/CD8+, the helper and cytotoxic subsets, are the major populations counted within the CD3 total. Their two reported counts need not add up to it exactly: some T cells carry neither marker and some carry both.

CD4/CD8 ratio describes the balance between them, which a total cannot show.

CD19+ B cells are the other arm of the lymphocyte count, reported on the same panel.

Absolute lymphocytes is the larger total that all of these are drawn from.

Clinical pearls

CD3 is a lineage marker: it identifies T cells, and LOINC classes it under CELLMARK.

Scale first — /uL and #/mm3 are identical, and a 10^9/L figure times 1,000 gives /uL. LOINC lists all three for this analyte.

The stored interval matches Labcorp's published adult CD3+ interval for test 096917.

Published intervals differ between populations, most at the lower bound.

HIV staging uses CD4, not CD3 — the CDC case definition does not mention CD3.

A CD3-positive population on a report is a statement of lineage, not of malignancy.

Clinical Takeaway

The absolute CD3 count enumerates total T-lymphocytes using CD3, the surface complex that marks mature T cells. It is reported in /uL, the identical #/mm3, or 10^9/L, which is multiplied by 1,000 to give /uL — all three listed under LOINC 8122-4. The range stored here, 622 - 2402 /uL, is Labcorp's published adult interval for test 096917 (58–86%); a 2021 reference-interval study in 496 healthy adults reported 834.47–2,216.8 cells/µL, so the lower bounds differ materially and the reader's own report governs. The panel's stated uses are classifying primary immunodeficiency and monitoring HIV — and in HIV it is CD4, not CD3, that stages disease, a point the CDC's 2014 case definition makes by never mentioning CD3. The count does not identify which subset is affected, does not measure T-cell function, and is a single day's snapshot. "CD3-positive" denotes T-cell lineage, not malignancy: benign CD3-positive populations arise in acute viral infection and resolve. Read it with the subsets reported beside it, against the range printed on the report, and with whoever ordered the panel.

In one sentence

The total T-cell headcount — useful alongside the subsets counted within it, and not a measure of how well those cells work.

Bottom line

Check the scale, then check whose range you are being compared against. CD3 counts your T cells; it does not grade them, it does not say which subset is involved, and it is not the number used to stage HIV — that is CD4. The figure belongs with the rest of the panel and the clinician who ordered it.